Have workplace or private cover? Ask the plan about the named product and the reason for treatment. Check if payment needs the plan’s agreement before the medicine is supplied; that is what advance approval means.
Does the reason for treatment change coverage?
The Medicare rules reviewed September 26, 2026 exclude regular drug coverage for medicine used only for weight loss. An approved use for another condition, such as diabetes, may allow coverage for that medicine.
Even for a use that can qualify, your Medicare drug plan still checks its medicine list and whether it must approve payment in advance.
If the plan says “formulary,” it means its medicine list. If it says “prior authorization,” it wants to approve payment ahead of time. Use the product name when asking how those rules apply.
What is the temporary Medicare option?
A temporary way to access certain weight-loss medicines is called the Medicare GLP-1 Bridge. Once eligible, a person pays $50 for each month’s supply through the program.
The program opened on July 1, 2026; its scheduled closing date is December 31, 2027.
The letters GLP-1 refer to a gut hormone; semaglutide copies its effects.
The Bridge pays through a separate system from your regular Medicare drug plan. It does not change that plan’s rule excluding medicine used for weight loss alone.
In the September 26, 2026 rules, eligible weight-treatment products included semaglutide (Wegovy), in tablet or injection form.
Could I qualify at age 80?
You must be at least 18 to meet the age rule; age 80 alone does not exclude you. You must also have qualifying Medicare drug coverage and meet the health rules.
The weight rules use body mass index (BMI), a number based on height and weight. The program checks your BMI and health when you began this kind of treatment.
- BMI 35 or more meets the weight rule without another illness from the list below.
- BMI 30 or more needs one of three other health problems. One is heart failure in which the heart squeezes normally but does not fill properly. Another is blood pressure that stays high despite two blood-pressure medicines: a bottom reading over 90 or a top reading over 140. The remaining condition is kidney disease that is long-term and has reached stage 3a or later.
- BMI 27 or more also needs another health problem. Blood sugar that is above normal but still below diabetes levels can meet this extra health rule. A past stroke or heart attack can also meet that rule. So can symptoms caused by narrowed arteries in the legs or arms.
People with type 2 diabetes use regular Medicare drug coverage instead of the Bridge. The same applies to moderate or severe breathing pauses during sleep caused by a blocked airway. Another excluded illness involves fat buildup and inflammation in the liver, with moderate or advanced scarring but without the severe scarring called cirrhosis. Have the person providing your care confirm the exact diagnosis; a fatty-liver illness does not always rule you out.
A prescription written to lower the risk of a heart attack, stroke or death from heart disease also goes through the regular drug plan.
For the Bridge in 2026, a GLP-1 medicine paid for that year by your Medicare drug plan makes you ineligible. The September 26 rules had not yet set that rule for 2027.
Drug coverage must come either from a separate Medicare drug plan or from Medicare Advantage cover that coordinates care and includes medicines. Some other plan types qualify only if you also have a separate drug plan. Check your exact plan type before counting on the Bridge.
A prescription and advance approval are required. Treatment must include ongoing changes in physical activity and eating habits alongside the prescribed medicine.
Will the $50 help pay off my other drug bills?
No part of the Bridge’s $50 payment counts toward your regular Medicare drug plan’s deductible, the amount you pay first for covered medicines. Your regular Medicare drug plan also leaves the Bridge payment out when counting your spending toward its yearly limit for covered medicines. Paying the Bridge’s $50 therefore does not bring you closer to either limit.
What do I ask my own plan?
- Does this exact product appear on my plan’s medicine list?
- Does the reason for treatment meet the coverage rules?
- Is advance approval needed, and who sends it?
- What will I owe if the plan approves it?
- What can I do if the plan declines?
Ask for the answer in writing if possible. A general statement that a drug can be covered is not a promise about your bill.